Signos
Burlingame
About Signos
Signos is on a mission to tackle the obesity epidemic via healthy habits, glucose level stabilization, and AI. Signos combines continuous glucose information with an AI-enhanced app to offer revolutionary continuous data and recommendations designed to drive healthy and sustained weight loss. With over 75% of the American population overweight or obese, Signos provides a new way for people to act on their body’s unique response to what they eat to lose weight and kickstart a healthier life
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $37.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2023)
- Website: signos.com
- Phone: [email protected]
Industries & Categories
Health Care, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/signos-79651 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.